I am a medical oncologist who specializes in the treatment of breast cancer and gastrointestinal malignancies like esophageal, pancreatic and colorectal cancers, as well as hepatocellular …

Anne P. Noonan joined Summit in 2020 after having served as President and Chief Executive Officer of OMNOVA Solutions Inc. (NYSE: OMN), a global producer of emulsion polymers, specialty chemicals, and decorative and functional surfaces, from …

Anne Noonan joined Summit in 2020 after having served as President and Chief Executive Officer of OMNOVA Solutions Inc. (NYSE: OMN), a global producer of emulsion polymers, specialty chemicals, and decorative and functional surfaces, from November 2016 through January 2020.

2024年12月30日 · Anne P. Noonan is currently the President, Chief Executive Officer & Director at Summit Materials LLC and Summit Materials, Inc. She is also an Independent Director at CF Industries Holdings, Inc., a Director at American Chemistry Council, Inc., and a Director at OMNOVA Performance Chemicals Ltd.

2022年11月4日 · Anne Noonan decided it was time to undertake a new challenge in a different industry. So, after a successful 30-plus-year career in the chemical industry, she took on the role of President and CEO of vertically integrated construction materials producer Summit Materials.

2020年7月21日 · Anne Noonan brings over 30 years of senior leadership experience at publicly traded materials companies. Most recently, Ms. Noonan served as President and Chief Executive Officer of OMNOVA Solutions Inc. (NYSE: OMN), a $760 million global producer of emulsion polymers, specialty chemicals, and decorative and functional surfaces, from November ...

2021年3月30日 · DENVER--(BUSINESS WIRE)-- Summit Materials, Inc. (NYSE: SUM, “Summit,” or the “Company”), a leading vertically integrated construction materials company, has named three senior leadership positions poised to drive the …

Anne Noonan is currently the President, Director, and CEO at Summit Materials. Anne has previous experience as the Chief Executive Officer at OMNOVA Solutions from September 2014 to April 2020, where they led a $2B global business.

Safety, efficacy and pharmacodynamics (PD) of MEDI9447 (oleclumab) alone or in combination with durvalumab in advanced colorectal cancer (CRC) or pancreatic cancer (panc). MJ Overman, P LoRusso, JH...

Anne P. Noonan is President, Chief Executive Officer & Director at Summit Materials LLC and President, Chief Executive Officer & Director at Summit Materials, Inc. She is also on the board of...